Gilead Sciences has received approval from EC for Trodelvy, for pre-treated HR-p...
The Indian pharma industry experienced a 23% drop in hiring activity in Q2 2023,...
NS Pharma’s candidate would be the first to target Duchenne Muscular Dystrophy (...
New research describes a flexible ultrasound that can be worn in a bra and could...
House Republicans have drafted legislation to address cancer and other drug shor...
AstraZeneca has been trying to ratchet up its rare disease efforts, spending $39...
"Until we understand how it happens, and how to stop it from happening, we're go...
Drug companies believe injectable versions of some cancer drugs are likely to be...
Biogen on Friday said it would acquire Reata Pharmaceuticals, the maker of an ap...
Without state and federal action, immigrants will face unequal access to U.S. ma...
Refusing to provide abortion information in order to minimize legal risk violate...
With profitability in sight, Talkspace is budding into a digital health success ...
Resistance from the University of Minnesota, whose main teaching hospital in Min...
WASHINGTON — At a House oversight hearing Thursday, the Biden administration’s t...
Republicans on Thursday sought to turn around transgender advocates’ arguments t...
More than two dozen prominent health policy experts are urging the Biden adminis...